54 753 (Letrozole 2.5 mg)
Pill imprint 54 753 has been identified as Letrozole 2.5 mg.
Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 54 753
- Strength:
- 2.5 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Aromatase inhibitors
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Roxane Laboratories, Inc
- National Drug Code (NDC):
- 00054-0269
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
silicon dioxide colloidal
magnesium stearate
sodium starch glycolate type A potato
pregelatinized corn starch
Note: Inactive ingredients may vary.
More about letrozole
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 99 Reviews – Add your own review/rating
- Drug class: aromatase inhibitors
Consumer resources
Other brands: Femara
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
